Northwire Canada EditionFriday, July 10, 2026
Sign inSubscribe
Northwire
⌕
S 0.160 +33.3% NNX 0.035 +0.0% ABX 52.02 −0.4% TTS 2.40 −4.0% FCI 0.400 −9.1% GR 0.075 +0.0% AII 23.38 +12.4% TUNG 1.73 +2.4% LGO 1.01 −2.9% EMM 0.080 +0.0% OGN 3.45 +2.1% MSA 6.52 +1.4% SGZ 0.040 −11.1% GRSL 0.310 −3.1% DEX 0.380 −1.3% WMS 0.040 +0.0% S 0.160 +33.3% NNX 0.035 +0.0% ABX 52.02 −0.4% TTS 2.40 −4.0% FCI 0.400 −9.1% GR 0.075 +0.0% AII 23.38 +12.4% TUNG 1.73 +2.4% LGO 1.01 −2.9% EMM 0.080 +0.0% OGN 3.45 +2.1% MSA 6.52 +1.4% SGZ 0.040 −11.1% GRSL 0.310 −3.1% DEX 0.380 −1.3% WMS 0.040 +0.0%
Financings Routine −

KDA GROUP COMPLETES DEBT SETTLEMENT

KDA Group Settles Debt with Equity Amidst Share Price Collapse

By The Northwire Desk — AI Analysis May 29, 2026 · 18:00 KDA · 0.08 KDA Group Inc.
Executive Summary
  • KDA Group Inc. announced the completion of a debt settlement previously announced on May 5, 2026.
  • The Corporation settled $25,000 in indebtedness by issuing 250,000 Class A Shares at $0.10 per share.
  • TSX Venture Exchange approval was received for the issuance.
  • Securities are subject to a hold period of four months and one day from date of issuance.
  • This follows the May 5 announcement regarding legal settlements with former executives which included cash payments and share issuances.
Material Impact
  • The debt settlement amount ($25,000) is immaterial relative to company size or operational scale.
  • Issuing shares at $0.10 when the market price has collapsed to $0.08 indicates a dilutive transaction occurring below current market valuation.
  • This reinforces a pattern of equity issuance for obligations (Nov 2025: 35M shares; May 2026: 250k shares), signaling potential liquidity constraints rather than operational strength.
  • The news does not introduce new revenue streams or strategic partnerships, merely closing out legacy financial liabilities.
  • Given the stock's significant decline over the past year, this incremental dilution is viewed negatively by risk-averse investors.
KDA · Price
Company Overview
  • Company: KDA Group Inc., a technology-focused healthcare SaaS company listed on TSX Venture Exchange.
  • Flagship Project: Medherize platform for therapeutic monitoring of oral anticancer therapies (OAM).
  • Operations: Deployed in Quebec hospitals (CHU de Québec, Hôpital du Saint-Sacrement) and community pharmacies (Horizon Santé, Jean Coutu).
  • Expansion: U.S. subsidiary opened to target the $243 billion specialty drug market starting 2026.
  • Subsidiary: Groupe Technologique KDA Inc. (GTK), now fully owned by KDA Group following acquisition of minority interest in late 2025.
Read the original news release →

More from KDA Group Inc.

Jun 18, 2026 · 13:15

Clinical validation of Medherize confirms value prop, but tiny revenue and depleted cash demand urgent capital raise.

Other May 05, 2026 · 13:30

Governance Cleanup Amidst Valuation Trough

Regulatory Dec 24, 2025 · 11:00

UPDATE OF THE TRANSACTION ANNOUNCED ON NOVEMBER 25, 2025, FOR THE ACQUISITION OF THE MINORITY INTEREST IN THE SUBSIDIARY GROUPE TECHNOLOGIQUE KDA INC.

M&A / Property Dec 03, 2025 · 10:30

KDA GROUP ANNOUNCES PARTNERSHIP AGREEMENT WITH CHU DE QUEBEC-UNIVERSITE LAVAL FOR THE DEPLOYMENT OF MEDHERIZE

M&A / Property Dec 01, 2025 · 13:45

KDA GROUP DEPLOYS MEDHERIZE ACROSS COMMUNITY PHARMACIES: A MAJOR STEP FORWARD IN THE MANAGEMENT OF ORAL ANTICANCER THERAPIES

Production / Operations Nov 25, 2025 · 15:00

KDA GROUP ANNOUNCES AGREEMENT TO ACQUIRE MINORITY INTEREST IN ITS SUBSIDIARY GROUPE TECHNOLOGIQUE KDA INC.

M&A / Property